Evidence map›Paper›PMID 42910346›Full record

ArticleEJHaem2026

Recurrent Steroid-Responsive Epiglottitis Following Cord Blood Transplantation: A Case Report.

Ryo Nakagawa, Koichi Onodera, Hikaru Kon, Mizuki Watanabe, Hiroaki Abe, Eiji Ogawa, Hikaru Kumagai, Toaki Maeda, Akihisa Kawajiri, Shunsuke Hatta and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ryo NakagawaDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Koichi OnoderaDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Hikaru KonDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Mizuki WatanabeDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Hiroaki AbeDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Eiji OgawaDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Hikaru KumagaiDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Toaki MaedaDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Akihisa KawajiriDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Shunsuke HattaDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Risako KakutaDepartment of Otolaryngology, Head and Neck Surgery Tohoku University Hospital Sendai Miyagi Japan.
Noriko FukuharaDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.
Hideo HarigaeDepartment of Hematology Tohoku University Hospital Sendai Miyagi Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epiglottitis is an acute inflammation of the epiglottis, typically caused by bacterial infections and potentially life-threatening due to rapid airway obstruction. There are extremely rare case reports of epiglottitis as a complication following allogeneic stem cell transplantation (allo-SCT). We report a 56-year-old female case with adult T-cell lymphoma (ATL) who suffered from recurrent epiglottitis after cord blood transplantation (CBT). Her epiglottitis was refractory to empirical antibiotic therapy. However, it responded promptly to corticosteroids, preventing the development of severe respiratory failure. This report implicated the importance of recognizing non-infectious epiglottic inflammation in the setting of transplantation and cellular therapy.

Indexed as

ATLcord blood transplantationepiglottitis

Identifiers

PMID42910346
PMCPMC13686589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.